Portfolio Lab

Direxion Daily S&P Biotech Bear 3X ETF

  • ETF
  • Ticker LABD
  • NYSE

Performance, volatility and drawdowns of Direxion Daily S&P Biotech Bear 3X ETF since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

LABDGlobal equities (VT)

$10,000 grew to $4. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −100.0% in 08/2026, measured from the peak in 12/2016. The old peak has not been reached again yet.

Factor profile

Monthly returns 12/2016 to 09/2026, measured against USA. The factors explain 61% of the variation.

Market
−2.12
Size
−3.03
Value
1.74
Profitability
1.99
Low investment
−0.24
Momentum
−0.28

How to read this: LABD moves less than the stock market (USA): when the market rises by 1%, the ETF rises by -2.12% on average. The ETF leans towards large companies, cheaply valued stocks (value) and profitable companies.

A value of 1 for the market means: when the market rises by 1%, the ETF rises by 1% on average. The other values show the lean towards small, cheaply valued, profitable, conservatively investing and recently strong stocks; bold where it is clear. Calculated with the Fama and French factors and momentum.

Open in factor analysis

Annual returns

Best year 2021 at +1.9%, weakest 2020 at −89.7%. 1 of 9 full years were positive. * partial year.

Similar ETFs

Frequently asked questions

How has LABD performed since 11/2016?

$10,000 grew to $4 by 20 Nov 2026, which is −54.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is LABD?

Volatility was 74.4% per year, measured on monthly returns. The largest decline from a peak was −100.0%, with the low in 08/2026.

How does LABD compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, LABD returned −54.6% at 74.4%. The correlation of monthly returns was -0.56; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Direxion Daily S&P Biotech Bear 3X ETF (LABD)